Harvest One Cannabis (TSX-V: $HVST.V) provides Satipharm Patent
Cooperation Treaty (PCT) Application update
VANCOUVER, British Columbia - August 23, 2017 (Investorideas.com
Newswire) Harvest One Cannabis Inc. (TSX-V:HVST) ("Harvest One" or
the "Company") is pleased to advise that the Patent Cooperation
Treaty ("PCT") application submitted by the Company's Swiss-based
subsidiary Satipharm AG ("Satipharm") in February 2017 has now been
published. This comprehensive patent application is directed at Satipharm's
proprietary Gelpell-CBD product technology, and covers oral formulations
utilising both singular and/or a combination of cannabinoids. Once granted, the
patent will be owned equally by Satipharm and its manufacturing partner Gelpell
AG ("Gelpell") and will also cover, via an exclusive agreement, the
cannabis-derived prescription drugs developed by PhytoTech Therapeutics Limited
("PTL").
The unique Gelpell-CBD product technology enables flexibility in
manufacturing a wide range of doses at various ratios of cannabinoids that can
be used for multiple indications and personalised medicine.
Read this news in full at http://www.investorideas.com/news/2017/marijuana/08231HarvestOne.asp
Marijuana
/ Hemp Stocks
Like
Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Join our
Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing
Watch the 420 Cannabis Investor video
This news is published on the Investorideas.com
Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC
Residents and global Investors: Effective September 15 2008 - all BC investors
should review all OTC and Pink sheet listed companies for adherence in new
disclosure filings and filing appropriate documents with Sedar. Read for more
info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment